CM
CLDX icon

Caption Management’s Celldex Therapeutics CLDX Stock Holding History

Caption Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,462
Closed -$167K – 1592
2024
Q4 		$189K Sell
7,462
-102,538
-93% -$2.79M ﹤0.01% 1288
2024
Q3 		$3.74M Buy
+110,000
New +$4.19M 0.06% 373
2024
Q1 		– Sell
-39,700
Closed -$1.63M – 1264
2023
Q4 		$1.57M Buy
39,700
+26,700
+205% +$785K 0.02% 679
2023
Q3 		$358K Buy
+13,000
New +$407K 0.01% 1007
2023
Q1 		– Sell
-5,000
Closed -$216K – 1145
2022
Q4 		$223K Sell
5,000
-5,944
-54% -$212K ﹤0.01% 1048
2022
Q3 		$307K Buy
+10,944
New +$336K ﹤0.01% 1177
2022
Q1 		– Sell
-26,500
Closed -$847K – 1514
2021
Q4 		$1.02M Sell
26,500
-46,500
-64% -$2.03M 0.01% 1041
2021
Q3 		$3.94M Buy
+73,000
New +$3.43M 0.05% 539

Other funds holding CLDX

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return